The impact of clonal size on the revised international prognostic scoring system (R-IPSS) in myelodysplastic syndromes (MDS) with a single cytogenetic abnormality

Authors :: Kebede H. Begna
Mark R. Litzow
Mrinal M. Patnaik
William J. Hogan
Hassan B. Alkhateeb
Rong He
Phuong L. Nguyen
Aref Al-Kali
Patricia T. Greipp
Omar Alkharabsheh
Naseema Gangat
Salwa S. Saadeh
Source :: Journal of Clinical Oncology. 36:7068-7068
Publication Year :: 2018
Publisher :: American Society of Clinical Oncology (ASCO), 2018.
Abstract: 7068Background: Cytogenetics is the backbone of the R-IPSS for MDS, contributing the most points (0 to 4) to the total scoring system. The current R-IPSS cytogenetics does not factor in the clone s...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Scoring system
business.industry
Myelodysplastic syndromes
Cytogenetics
Clone (cell biology)
urologic and male genital diseases
medicine.disease
International Prognostic Scoring System
Cytogenetic Abnormality
Internal medicine
Medicine
business

Full Text Access

Tools